NCT02117713
An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome
Phase: Phase 2
Role: Collaborator
Start: Mar 16, 2015
Completion: Jun 1, 2020